Mitchell S. V. Elkind

Epidemiology · 2005–2021

A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

Whom Mitchell S. V. Elkind trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Peter Libby

Who trusts Mitchell S. V. Elkind overall

  1. Benjamin Letham
  2. Cynthia Rudin
  3. Tyler H. McCormick

Papers from Mitchell S. V. Elkind's perspective

Ordered by how strongly the researchers Mitchell S. V. Elkind trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (Annals of Internal Medicine)
  2. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. (The Lancet)
  3. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.
  4. Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies (Circulation)
  5. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. (Kidney International)
  6. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (New England Journal of Medicine)
  7. Warfarin, aspirin, or both after myocardial infarction. (New England Journal of Medicine)
  8. Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking (Circulation)
  9. Epidemiology of obstructive sleep apnea: a population health perspective. (American Journal of Respiratory and Critical Care Medicine)
  10. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis (British medical journal)

Their papers